SCP
NTUS

Seizert Capital Partners’s Natus Medical Inc NTUS Stock Holding History

Seizert Capital Partners’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,480
Closed -$533K – 225
2021
Q4 		$533K Sell
22,480
-9,394
-29% -$232K 0.02% 173
2021
Q3 		$799K Sell
31,874
-1,570
-5% -$40K 0.04% 146
2021
Q2 		$869K Buy
33,444
+17,173
+106% +$467K 0.04% 138
2021
Q1 		$417K Buy
16,271
+4,453
+38% +$114K 0.02% 145
2020
Q4 		$237K Buy
+11,818
New +$231K 0.01% 178

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Seizert Capital Partners's NTUS Position: Q1 2022 in Review

Seizert Capital Partners sold out of Natus Medical Inc (NTUS) in Q1 2022, closing a stake of 22,480 shares — an estimated $533K sold.

Seizert Capital Partners first reported a position in NTUS in Q4 2020 and held it in 5 quarters. The position peaked at $869K in Q2 2021. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.

  • Seizert Capital Partners reported no remaining Natus Medical Inc position as of Q1 2022 after selling out during the quarter.
  • Seizert Capital Partners sold 22,480 Natus Medical Inc shares in Q1 2022, an estimated $533K.
  • Seizert Capital Partners first reported a position in Natus Medical Inc in Q4 2020 and held it in 5 quarters.
  • Seizert Capital Partners's Natus Medical Inc position peaked at $869K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.

Based on Seizert Capital Partners's 13F filing for Q1 2022, filed 3 May 2022.